OR WAIT null SECS
February 03, 2024
Technical, regulatory, and personnel considerations characterize pharmaceutical compounding.
January 10, 2024
Nanoform has completed the First Subject First Visit in a trial evaluating the relative bioavailability of its nanotechnology-enhanced enzalutamide.
January 05, 2024
MediWound has been granted an additional $6.7 million by the DoD to advance NexoBrid as a non-surgical field care solution for the US military.
December 18, 2023
December 03, 2023
Matching excipients to API properties is essential.
Collaboration is a key component to achieving long-term success with genetic medicines.
November 06, 2023
Pharmaceutical Technology Europe® spoke with Ole Wiborg from Zerion Pharma, a Danish pharmaceutical development company, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.
November 03, 2023
Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, recommends some key issues that pharma manufacturers should consider when formulating products that require a medical device.
Pharmaceutical Technology Europe® spoke with Gustavo Ferrer from Dr. Ferrer BioPharma, a US company focused on innovative intranasal medications, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.
Predictive modeling facilitates the identification of coformers, cocrystal components, and complexing agents.